Las Vegas CRWENewswire.com is pleased to announce a stock highlight on LOS ANGELES (CRWENewswire)
According to Charles Mandeville, Chemist, SRS Engineering, Inc. "The CTI BioForce 9000 is doing its job very well, providing excellent conversion rates, exceeding all our expectations and performance requirements. The fuel quality is the best we have ever seen."
Roman Gordon, CTI CEO, stated, "We knew that our unit would provide excellent performance and are very pleased by this news confirming our technology performs much better than others. We believe there is a bright future for BioForce 9000, which offers many advantages for new production plants, which gives them an edge over other producers. Feedstock flexibility, higher yields and top quality fuel will allow plants to be more profitable than existing producers. This will show existing plants that by replacing older outdated technologies, they can improve profitability as well." Mr. Gordon went on further to say, "We have many clients who are now moving forward with their projects for new plants in South America, Asia and other parts of the world."
CTI's BioForce 9000 nano-cavitation biodiesel reactor is a unique low cost single stage reactor and is the most advanced system available today for quality biodiesel production. The BioForce 9000 offers substantial savings over existing technologies, which reduce equipment, and production costs substantially. Its ability to process multiple feedstocks and reduce energy costs is a significant advantage for producers.
The Producer's Choice Soy Energy is the first of many companies, which are planning to utilize CTI's BioForce 9000 and SRS systems technologies. The plant was designed and constructed by Process Concepts (www.processconcepts.com)
About Cavitation Technologies
Cavitation Technologies, Inc. (CTI); (OTCBB: CVAT - News); is a "Green-Tech"
Safe Harbor: Pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995, and within the meaning of Section 27A of the Securities Act of 1933 and Section 21B of the Exchange Act of 1934, any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals and assumptions of future events or performance are not statements of historical fact and may be "forward-looking statements."
For Further Information Contact:
Cavitation Technologies
(818) 718-0905
info@cavitationtechnologies.com
IR@cavitationtechnologies.co
********************************
Disclaimer: Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment (read more) Rule 17B requires disclosure of payment for investor relations.



